{"doi":"10.1021/jacs.7b00280","title":"Peptide Metal–Organic Frameworks for Enantioselective Separation of Chiral Drugs","abstract":null,"journal":"Journal of the American Chemical Society","year":2017,"id":683939,"datarank":0.8671115273688494,"base_score":5.780743515792329,"endowment":5.780743515792329,"self_citation_contribution":0.8671115273688494,"citation_network_contribution":0.0,"self_endowment_contribution":0.8671115273688494,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":323,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1786748,"name":"Ana I. Argente-García","orcid":null,"position":1,"is_corresponding":false},{"id":1786749,"name":"Yolanda Moliner-Martínez","orcid":null,"position":2,"is_corresponding":false},{"id":1786750,"name":"Daniel Roca-Sanjuán","orcid":null,"position":3,"is_corresponding":false},{"id":1786751,"name":"Dmytro Antypov","orcid":null,"position":4,"is_corresponding":false},{"id":1786752,"name":"Pilar Campíns-Falcó","orcid":"0000-0002-0980-8298","position":5,"is_corresponding":false},{"id":1263168,"name":"Matthew J. Rosseinsky","orcid":"0000-0002-7077-6125","position":6,"is_corresponding":false},{"id":876058,"name":"Carlos Martí‐Gastaldo","orcid":"0000-0003-3203-0047","position":7,"is_corresponding":false},{"id":1786747,"name":"José Navarro-Sánchez","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Peptide Metal–Organic Frameworks for Enantioselective Separation of Chiral Drugs","abstract":"We report the use of a chiral Cu(II) 3D metal-organic framework (MOF) based on the tripeptide Gly-l-His-Gly (GHG) for the enantioselective separation of metamphetamine and ephedrine. Monte Carlo simulations suggest that chiral recognition is linked to preferential binding of one of the enantiomers as a result of either stronger or additional H-bonds with the framework that lead to energetically more stable diastereomeric adducts. Solid-phase extraction of a racemic mixture by using Cu(GHG) as the extractive phase permits isolating >50% of the (+)-ephedrine enantiomer as target compound in only 4 min. To our knowledge, this represents the first example of a MOF capable of separating chiral polar drugs.","is_dataset_classified":null,"base_score":5.780743515792329,"endowment":5.780743515792329,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"28274119","pmcid":null,"openalex_id":"https://openalex.org/W2592766538","authors":[],"funders":[{"funder_name":"Generalitat Valenciana","grant_id":"GV/2016/137","title":null},{"funder_name":"Generalitat Valenciana","grant_id":"Prometeo 2016/109","title":null},{"funder_name":"Ministerio de Econom?a y Competitividad","grant_id":"CTQ-2014-53916-P","title":null},{"funder_name":"Ministerio de Econom?a y Competitividad","grant_id":"MDM-2015-0538","title":null},{"funder_name":"H2020 European Research Council","grant_id":"714122","title":"Chemical Engineering of Functional Stable Metal-Organic Frameworks: Porous Crystals and Thin Film Devices"},{"funder_name":"Engineering and Physical Sciences Research Council","grant_id":"EP/J008834/1","title":null}],"total_grants":6,"fwci":10.6589,"citation_percentile":0.98974777,"influential_citations":0,"citation_trend":[{"year":2017,"count":14},{"year":2018,"count":35},{"year":2019,"count":30},{"year":2020,"count":42},{"year":2021,"count":45},{"year":2022,"count":37},{"year":2023,"count":37},{"year":2024,"count":42},{"year":2025,"count":26},{"year":2026,"count":15}],"oa_status":"green","license":"cc-by-nc","oa_locations":[{"url":"http://hdl.handle.net/10550/68465","host_type":"repository"},{"url":"http://hdl.handle.net/10550/68465","host_type":"repository"},{"url":"https://pubs.acs.org/doi/pdf/10.1021/jacs.7b00280","host_type":"publisher"},{"url":"https://doi.org/10.1021/jacs.7b00280","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/28274119","host_type":"repository"},{"url":"https://roderic.uv.es/bitstream/10550/68465/1/117899.pdf","host_type":""},{"url":"http://livrepository.liverpool.ac.uk/3006722/1/2017-05-12T11:29:30Z.atom","host_type":""},{"url":"https://dx.doi.org/10.1021/jacs.7b00280","host_type":""},{"url":"https://hdl.handle.net/10550/68465","host_type":""},{"url":"http://dx.doi.org/10.1021/jacs.7b00280","host_type":""}],"fields_of_study":["Metal-Organic Frameworks: Synthesis and Applications","Mass Spectrometry Techniques and Applications","Molecular Sensors and Ion Detection","01 natural sciences","0104 chemical sciences","Copper","Ephedrine","Metal-Organic Frameworks","Methamphetamine","Molecular Dynamics Simulation","Molecular Structure","Monte Carlo Method","Peptides","Stereoisomerism"],"mesh_terms":["Metal-Organic Frameworks","Copper","Ephedrine","Methamphetamine","Monte Carlo Method","Peptides","Stereoisomerism","Molecular Structure","Molecular Dynamics Simulation"],"keywords":["Chemistry","Enantioselective synthesis","Diastereomer","Enantiomer","Tripeptide","Ephedrine","Metal-organic framework","Combinatorial chemistry","Adduct","Phase (matter)","Organic chemistry","Racemic mixture","Stereochemistry","Computational chemistry","Peptide","Catalysis","Molecular Structure","Stereoisomerism","Química","Molecular Dynamics Simulation","Methamphetamine","Pèptids","Peptides","Monte Carlo Method","Copper","Metal-Organic Frameworks"],"sdg_mappings":[{"sdg_number":13,"sdg_label":"13. Climate action"},{"sdg_number":0,"sdg_label":"Clean water and sanitation"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-18T12:47:07.453628Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}